Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Methenamine (also known as hexamethylenetetramine) is an antiseptic agent that has been used for the prevention and treatment of urinary tract infections (UTIs), including some cases of kidney infections (pyelonephritis). Its mechanism of action is based on the hydrolysis of methenamine in acidic urine to produce formaldehyde, which acts as a nonspecific bactericidal agent. The use of methenamine is supported by clinical studies that demonstrate its efficacy in reducing the recurrence of lower urinary tract infections, particularly in patients who are at risk for frequent, recurrent UTIs and in whom long-term antibiotic therapy is undesirable due to concerns about resistance. However, methenamine is not typically recommended as first-line therapy for acute kidney infections (pyelonephritis), especially in severe cases, because it is less effective than antibiotics at treating established infections and relies on the acidity of the urine for activation. Its use is more justified as a prophylactic agent to prevent recurrent infections rather than to treat acute, symptomatic kidney infection. Guidelines such as those from the Infectious Diseases Society of America (IDSA) acknowledge the preventive role of methenamine in select patients, but emphasize that acute pyelonephritis should be treated with antibiotics. In summary, methenamine’s use in kidney infection is scientifically validated for prevention but is not a substitute for antibiotics in acute infections. Its evidence rating is moderate (3/5), reflecting its niche role and limitations.

More about methenamine
More about Kidney Infection

Other ingredients used for Kidney Infection

Other health conditions supported by methenamine

Products containing methenamine